London [United Kingdom], November 16 (ANI): Medical regulators in the UK have approved a gene therapy, that aims to cure two blood disorders-sickle-cell disease and beta-thalassemia.
After rigorous testing on safety, quality and effectiveness, Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the world’s first gene therapy, that will work to treat sickle-cell disease as well as B-thalasse
UK approves world’s first gene therapy for sickle cell disease, beta thalassemia
